Claudio Laudani: We Summarize Current Knowledge and Future Perspectives On The Role of Inflammation in Patients with MI
Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared on LinkedIn:
”Inflammation is a key driver of ischemic heart disease and myocardial infarction, having a central role in both the arterial wall and myocardial tissue.
Recently, novel approaches have reignited the interest in anti-inflammatory strategies after acute myocardial infarction.
However, key knowledge gaps remain regarding potential class effects, drug choice, patient selection, and the optimal administration timing.
In this state of the art review, we summarize current knowledge and future perspectives on the role of inflammation in patients with myocardial infarction, as well as potential targets and pharmacological treatments being currently under development.”
Read the full article in JACC.
Article: Targeting Inflammation After Acute Myocardial Infarction
Authors: Antonino Imbesi, Antonio Greco, Marco Spagnolo, Claudio Laudani, Carmelo Raffo, Simone Finocchiaro, Placido Maria Mazzone, Davide Landolina, Maria Sara Mauro, Luigi Cutore, Giacinto Di Leo, Denise Cristiana Faro, Nicola Ammirabile, Daniele Giacoppo, Davide Capodanno
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Oct 8, 2025, 03:07Stroke Education By Rodrigo Guerrero - On Unilateral, Nonprogressive Stenosis
-
Oct 7, 2025, 15:015 Simple Exercises By Christina P. That Support Health in Antiphospholipid Syndrome
-
Oct 7, 2025, 14:39Dr Amid Karad: Help Raise Awareness on Evidence-Based INR Management for Diverse Indications
-
Oct 7, 2025, 14:27NBCA Insights with Erin VanDyke: Revealing Gaps in Blood Clot Diagnosis and Support
-
Oct 7, 2025, 14:26Caitlin Raymond: When to Use Albumin vs. Plasma, and Why the Timing Matters
-
Oct 8, 2025, 04:50Christopher Cannon Shares A Study Showing No Benefit When Adding an Antiplatelet to Anticoagulant in Stroke with AF and Atherosclerosis
-
Oct 8, 2025, 04:41Claudio Laudani: We Summarize Current Knowledge and Future Perspectives On The Role of Inflammation in Patients with MI
-
Oct 8, 2025, 04:03José Antonio García Erce: Honored For Publishing in SANGRE Magazine
-
Oct 8, 2025, 03:57Mattia Galli On Genomadix Cube Test: A Rapid Genetic Test to Predict The Response to Clopidogrel
-
Oct 8, 2025, 03:54Rory R Koenen on Platelet-Derived Extracellular Vesicle Analogues from Lyophilized Platelets
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 8, 2025, 04:45Reza Shojaei: On The 2nd Day of IPAW 2025, Let's Focus on Patients, The Real Reason Plasma Matters!
-
Oct 7, 2025, 08:29“48 Poems on 48 Blood Group Systems” - Dr Bhavyaa Beriwal Blends Science and Poetry in Her New Transfusion Medicine Book
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
-
Oct 7, 2025, 04:09Svenja Tatjana Barckhausen: Reducing Reliance on U.S. Plasma – Not Just for Europe, But for The World!
-
Oct 7, 2025, 03:58Louise Bannon: Don’t Wait Until You’re Diagnosed to Learn About Blood Clots